PSMA-positive tumor
Conditions
Interventions
Gold Standard:Pathological biopsy or recognized diagnostic criteria
tumor 
biomarker, 
PET/CT
Sponsors
Tongji Hospital,Tongji Medical College, Huazhong University of Science and Technology
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Patients with PSMA-positive tumors including prostate cancer, breast cancer, lung cancer, and other tumor types know to express PSMA; 2. Patients able to tolerate PET/CT scans; 3. Informed consent must be given and signed.
Exclusion criteria
Exclusion criteria: 1. Subjects who do not meet the above mentioned inclusion criteria; 2. Subjects who refuse to give and/or sign the informed consent; 3. Patients who are currently pregnant or breast feeding; 4. Patients who are unable to undergo PET/CT scanning.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| T/B;tumor marker; | — |
Primary
| Measure | Time frame |
|---|---|
| SUV;Pathology;SEN, SPE, ACC, AUC of ROC; | — |
Countries
China
Contacts
Public ContactXiaohua Zhu
Department of Nuclear Medicine & PET/CT, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Outcome results
None listed